SIRT۵ prevents mitochondrial dysfunction and cardiac hypertrophy induced by RIP۱۴۰

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 107

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-28-4_009

تاریخ نمایه سازی: 8 اسفند 1403

چکیده مقاله:

Objective(s): To investigate the effect and mechanism of Sirtuin۵ (SIRT۵) on mitochondrial dysfunction and cardiac hypertrophy induced by receptor-interacting protein ۱۴۰ (RIP۱۴۰).Materials and Methods: The neonatal rat cardiomyocytes (NRCMs) and SD rats were treated with Angiotensin II (Ang II) to induce in vitro and in vivo model of cardiac hypertrophy. RIP۱۴۰ was overexpressed by adenovirus infection, and SIRT۵ was overexpressed by plasmid transfection. RIP۱۴۰ and SIRT۵ were knocked down by siRNA interference. The expression of RIP۱۴۰, SIRT۵, and biomarkers of cardiac hypertrophy were measured by qRT-PCR and western blot. The transcription levels of mitochondrial DNA-encoded genes were detected by qRT-PCR. Cell surface area and mitochondrial membrane potential were respectively detected by rhodamine-phalloidin and tetramethylrhodamine ethyl ester (TMRE) fluorescence analysis. Cellular oxygen consumption and ATP production were investigated using assay kits. All data are from at least three independent experiments.Results: The expression of SIRT۵ was down-regulated in NRCMs and hearts treated with Ang II. Overexpression of SIRT۵ protected cardiomyocytes from AngII-induced hypertrophy, whereas knockdown of SIRT۵ resulted in cardiac hypertrophy. Moreover, since SIRT۵ was regulated by the transcriptional coactivator, we also found that SIRT۵ could be negatively regulated by the transcriptional corepressor RIP۱۴۰ in cardiomyocytes. Furthermore, SIRT۵ significantly attenuated energy metabolic dysregulation and mitochondrial dysfunction and exerted its protective role on myocardial hypertrophy under the regulation of RIP۱۴۰.Conclusion: SIRT۵ exerts a protective role in mitochondrial dysfunction and cardiac hypertrophy induced by RIP۱۴۰.

نویسندگان

Liying Liang

Department of Pharmacy, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

Yi Huang

Guangzhou Special Service Recuperation Center of PLA Rocket Force, Guangzhou, Guangdong, China

Qiujuan Wang

Department of Pharmacy, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

Ye Hong

Department of Pharmacy, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

Honghui Zhen

Department of Pharmacy, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

Yanfang Chen

Department of Pharmacy, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Hardt SE, Sadoshima J. Negative regulators of cardiac hypertrophy. Cardiovasc ...
  • Martin TG, Juarros MA, Leinwand LA. Regression of cardiac hypertrophy ...
  • Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW, ...
  • Wu J, Lu J, Huang J, You J, Ding Z, ...
  • Roe AT, Aronsen JM, Skardal K, Hamdani N, Linke WA, ...
  • Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. ...
  • Gertz M, Steegborn C. Using mitochondrial sirtuins as drug targets: ...
  • Newman JC, He W, Verdin E. Mitochondrial protein acylation and ...
  • Yue Z, Ma Y, You J, Li Z, Ding Y, ...
  • Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, ...
  • Xiao ZP, Lv T, Hou PP, Manaenko A, Liu Y, ...
  • Sadhukhan S, Liu X, Ryu D, Nelson OD, Stupinski JA, ...
  • Gertz M, Steegborn C. Function and regulation of the mitochondrial ...
  • Liu B, Che W, Zheng C, Liu W, Wen J, ...
  • Boylston JA, Sun J, Chen Y, Gucek M, Sack MN, ...
  • Herzog B, Hallberg M, Seth A, Woods A, White R, ...
  • Seth A, Steel JH, Nichol D, Pocock V, Kumaran MK, ...
  • Chen Y, Chen S, Yue Z, Zhang Y, Zhou C, ...
  • Chen Y, Wang Y, Chen J, Chen X, Cao W, ...
  • Fritah A, Steel JH, Nichol D, Parker N, Williams S, ...
  • Yamamoto T, Maurya SK, Pruzinsky E, Batmanov K, Xiao Y, ...
  • Buler M, Aatsinki SM, Izzi V, Uusimaa J, Hakkola J. ...
  • Zhou SG, Zhou SF, Huang HQ, Chen JW, Huang M, ...
  • Da Dalt L, Cabodevilla AG, Goldberg IJ, Norata GD. Cardiac ...
  • Ng SM, Neubauer S, Rider OJ. Myocardial metabolism in heart ...
  • Wasyluk W, Nowicka-Stazka P, Zwolak A. Heart metabolism in sepsis-induced ...
  • Bertero E, Maack C. Metabolic remodelling in heart failure. Nat ...
  • Zhou B, Tian R. Mitochondrial dysfunction in pathophysiology of heart ...
  • Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart ...
  • Long Q, Yang K, Yang Q. Regulation of mitochondrial ATP ...
  • Lu X, Yang P, Zhao X, Jiang M, Hu S, ...
  • Meng T, Li FS, Xu D, Jing J, Li Z, ...
  • Zhou L, Wang F, Sun R, Chen X, Zhang M, ...
  • Wei C, Shi M, Dong S, Li Z, Zhao B, ...
  • You J, Yue Z, Chen S, Chen Y, Lu X, ...
  • Zhang L, Chen Y, Yue Z, He Y, Zou J, ...
  • نمایش کامل مراجع